C12Q 2521/325
Single stranded exonuclease
C12Q2521/325 (Single stranded exonuclease) appears on 7 US grants and 10 published applications in this corpus.
Search patents in C12Q- Granted patents
- 7
- Published applications
- 10
- Assignees
- 7
- Inventors
- 19
- Latest grant
- 4 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 1 | 1 |
| 2019 | 1 | 0 |
| 2020 | 1 | 2 |
| 2021 | 0 | 2 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Methods and compositions for enriching nucleic acids4 Mar 2025US 12,241,115 B2Asklepios Biopharmaceutical, Inc.
- Compositions and methods for quantifying a nucleic acid sequence in a sample23 Jul 2024US 12,043,866 B2Envirologix Inc.
- Compositions and methods for quantifying a nucleic acid sequence in a sample30 Aug 2022US 11,427,863 B2Envirologix Inc.
- Thermolabile exonucleases29 Sep 2020US 10,787,702 B2Arcticzymes AS
- Thermolabile exonucleases17 Sep 2019US 10,415,082 B2Arcticzymes AS
- Methods and compositions for enriching nucleic acids11 Sep 2025US 2025/0283148 A1Asklepios Biopharmaceutical, Inc.
- Methods and compositions for enriching nucleic acids17 Jun 2021US 2021/0180111 A1Asklepios Biopharmaceutical, Inc.
- Improved Method to Analyze Nucleic Acid Contents from Multiple Biological Particles4 Feb 2021US 2021/0032693 A1RootPath Genomics, Inc.
- Thermolabile exonucleases22 Oct 2020US 2020/0332352 A9Arcticzymes AS
- Thermolabile exonucleases5 Mar 2020US 2020/0071753 A1Arcticzymes AS
Most cited
By later US patents